I suspect that the share price has been depressed by shareholders selling to take up the rights issue. At the current price this is still a very profitable strategy. I am a bit surprised that the price has held up as well as it has. It is a testament to the appeal of the assets.
- Forums
- ASX - By Stock
- IVX
- SP v Entitlement offer price
SP v Entitlement offer price, page-2
Featured News
Add IVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $20.44M |
Open | High | Low | Value | Volume |
0.2¢ | 0.3¢ | 0.2¢ | $26.46K | 13.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1994375 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 10739626 | 50 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1994375 | 0.002 |
33 | 52474325 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 10739626 | 50 |
0.004 | 13620494 | 19 |
0.005 | 5198292 | 18 |
0.006 | 1655059 | 5 |
0.007 | 962000 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online